Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Consolidated Planning Corp

Consolidated Planning Corp grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 19.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,103 shares of the company’s stock after acquiring an additional 516 shares during the period. Consolidated Planning Corp’s holdings in Cardinal Health were worth $313,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CAH. Ameriprise Financial Inc. grew its stake in shares of Cardinal Health by 82.2% during the third quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after purchasing an additional 1,862,291 shares in the last quarter. California Public Employees Retirement System grew its stake in shares of Cardinal Health by 118.9% during the fourth quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock worth $152,816,000 after purchasing an additional 823,520 shares in the last quarter. International Assets Investment Management LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth $464,800,000. Deutsche Bank AG grew its stake in shares of Cardinal Health by 64.9% during the third quarter. Deutsche Bank AG now owns 1,027,670 shares of the company’s stock worth $89,222,000 after purchasing an additional 404,609 shares in the last quarter. Finally, Pacer Advisors Inc. grew its stake in shares of Cardinal Health by 17.5% during the fourth quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock worth $264,052,000 after purchasing an additional 389,431 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock traded down $0.60 during midday trading on Friday, reaching $103.21. 1,399,916 shares of the company traded hands, compared to its average volume of 1,705,735. The firm’s 50 day simple moving average is $109.51 and its two-hundred day simple moving average is $104.76. Cardinal Health, Inc. has a 1-year low of $77.56 and a 1-year high of $116.04. The firm has a market cap of $25.10 billion, a PE ratio of 40.63, a price-to-earnings-growth ratio of 1.04 and a beta of 0.68.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The company had revenue of $57.45 billion during the quarter, compared to the consensus estimate of $57.02 billion. During the same period last year, the firm earned $1.32 EPS. The company’s revenue for the quarter was up 11.6% on a year-over-year basis. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

Analysts Set New Price Targets

CAH has been the subject of a number of analyst reports. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. UBS Group upped their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a report on Monday, February 5th. Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Finally, SVB Leerink began coverage on shares of Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $103.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.